241 [250 max] Text: 2975 [3000 max] References: 40 [40 max] KEYWORDS HIV; preexposure prophylaxis; sexually transmitted infections; screening; men who have sex with men SUMMARY Nearly half of U.S. men who have sex with men in PrEP care are not receiving consistent bacterial STI screening at sites of sexual exposure, and levels are worse in the Southeast region where the burden of STI is highest.ABSTRACT Background The U.S. Centers for Disease Control and Prevention (CDC) recommends comprehensive sexually transmitted infection (STI) screening every 3-6 months for men who have sex with men (MSM) using HIV preexposure prophylaxis (PrEP). The gaps between these recommendations and clinical practice by region have not been quantified.
MethodsWe collected data between 2017 and 2019 on STI screening among MSM across the U.S., stratified by current, prior, and never PrEP use. Poisson regression models with robust error variance were used to model factors, including residence in the Southeast states, associated with consistent exposure site-specific STI screening during PrEP care.
ResultsOf 3259 HIV-negative MSM, 19% were currently using PrEP, 6% had used PrEP in the past, and 75% had never used PrEP. Among ever PrEP users, 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab, or pharyngeal swab, respectively, during PrEP care. Compared to PrEP users in all other regions, PrEP users in the Southeast were significantly less likely to be consistently screened for urogenital [adjusted prevalence ratio (aPR): 0.86, 95% confidence interval (CI): 0.76, 0.98] and rectal STIs (aPR: 0.76, 95% CI: 0.62, 0.93) during PrEP care.Conclusions Substantial gaps exist between CDC recommendations for STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngeal exposure sites that can harbor asymptomatic infections and for MSM in Southeast states where the STI burden is substantial.